- The HLDA8 blind panel: findings and conclusions
Number of the records: 1  

The HLDA8 blind panel: findings and conclusions

  1. 1.
    SYSNO ASEP0027620
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JOstatní články
    TitleThe HLDA8 blind panel: findings and conclusions
    TitleSlepý panel HLDA8: poznatky a závěry
    Author(s) Swart, B. (AU)
    Salganik, M.P. (US)
    Wand, M.P. (AU)
    Tinckam, K. (US)
    Milford, E.L. (US)
    Drbal, Karel (UMG-J)
    Angelisová, Pavla (UMG-J) RID
    Hořejší, Václav (UMG-J) RID
    Macardle, P. (AU)
    Bailey, S. (AU)
    Hollemweguer, E. (US)
    Hodge, G. (AU)
    Nairn, J. (AU)
    Millard, D. (AU)
    Dagdeviren, A. (TR)
    Dandie, G.W. (AU)
    Zola, H. (AU)
    Source TitleJournal of Immunological Methods. - : Elsevier - ISSN 0022-1759
    Roč. 305, č. 1 (2005), s. 75-83
    Number of pages9 s.
    Languageeng - English
    CountryNL - Netherlands
    KeywordsCD molecules ; leukocyte antigen
    Subject RIVEC - Immunology
    CEZAV0Z5052915 - UMG-J
    AnnotationThere were over 600 antibodies submitted to HLDA8, with many of unknown specificity. Of these, 101 antibodies were selected for a blind panel study that also included 5 negative controls and 27 positive controls of known CD specificity making a total of 133 antibodies in the final panel. Of the 101 unknowns, 31 antibodies were identified during the course of this blind panel study as being specific for known molecules and included some specific for MHC class II antigens, CD45 isoforms and the Dombrock antigen. Several antibody pairs among those in the blind panel were found to have very similar staining patterns and were therefore compared by immunohistochemical and/or Western blot analyses for identity.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2006
Number of the records: 1  

Metadata are licenced under CC0

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.